Antibacterial in vitro effects of preparations from Anthroposophical Medicine

Eva Roser1, Carsten Gründemann1, Inge Engels2

  • 1Center for Complementary Medicine, Freiburg, Germany.

Abstract

Insights

Anthroposophical Medicine preparation Berberis Decoctum D2 shows antibacterial effects against Staphylococcus aureus, including resistant strains. Further research is needed to explore its potential in treating bacterial infections.

Area of Science:

  • Pharmacology
  • Microbiology
  • Complementary Medicine

Background:

  • Anthroposophical Medicine (AM) preparations are used for infections but lack scientific evaluation of antibacterial properties.
  • This study aimed to assess the antibacterial activity of AM medications in a laboratory setting.

Purpose of the Study:

  • To investigate the in vitro antibacterial effects of selected Anthroposophical Medicine preparations.
  • To identify specific AM medications with potential antibacterial activity against common pathogens.

Main Methods:

  • Screened AM drug registers for non-alcoholic preparations (≤D2) used for infections.
  • Tested selected medications against Bacillus subtilis, Escherichia coli, Staphylococcus aureus, and Pseudomonas aeruginosa using agar diffusion.
  • Determined growth kinetics and minimal inhibitory concentrations (MIC) for active preparations.

Main Results:

  • Thirty-three AM preparations were screened; only Berberis Decoctum D2 showed significant antibacterial activity.
  • Berberis Decoctum D2 exhibited bactericidal effects against Bacillus subtilis and Staphylococcus aureus, including methicillin-resistant Staphylococcus aureus (MRSA).
  • The minimal inhibitory concentration (MIC) for Berberis Decoctum D2 was 5 mg/ml, with effects attributed to berberine content; no activity against Gram-negative bacteria was observed.

Conclusions:

  • Berberis Decoctum D2, an Anthroposophical Medicine preparation, demonstrates bactericidal effects against Staphylococcus aureus, including MRSA.
  • The findings support the traditional use of Berberis Decoctum D2 for infections caused by susceptible bacteria.
  • Further investigation into the active compound berberine and its mechanisms against Gram-positive bacteria is warranted.